Overworked Doctors Bet on AI to Boost Their Pay

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced new data indicating that physicians are finding an unexpected source of optimism in AI. Rather than viewing the technology as a threat, nearly a quarter expect it to increase their total compensation within the next year, and two-thirds believe staying current with AI will give them a meaningful earnings edge over peers who don't. The findings are part of Dox.

Business Wire • Aug 25, 2026

Reasons to Retain Doximity Stock in Your Portfolio for Now

DOCS' AI expansion is opening new growth avenues, but rising AI costs and tight pharma budgets could temper near-term gains.

Zacks Investment Research • Aug 24, 2026

Doximity's New CFO Just Filed His First Form 4. Here's What Long-Term Investors Should Know.

The disposition involved 15,311 shares valued at about $380,000 based on a weighted average price of $24.80 per share. The transaction reduced the insider's direct holdings by 3% following the underlying vesting event.

The Motley Fool • Aug 18, 2026

Doximity's Co-Founder Just Filed a Form 4. Is There Anything in It Worth Worrying About?

The CEO disposed of 8,505 shares for approximately $211,000 based on the transaction-date pricing. This transaction represented just 0.3% of the executive's direct equity holdings.

The Motley Fool • Aug 18, 2026

Doximity Handed Its President 150,000 Options Last Month. Here's What the Latest Filing Signals for Investors

The shares traded represent about $111,154 in total value based on the execution price on August 15. This disposition reduced the insider's direct equity holdings by 8%.

The Motley Fool • Aug 18, 2026

What Investors Should Know of This Doximity Officer's Latest Insider Transaction

The transaction involved the exercise of options and a subsequent disposition valued at $140,400 at $24.84 per share. The activity was split between a Rule 10b5-1 trading plan sale to cover tax obligations and mandated shares withheld by the issuer for restricted stock unit vesting.

The Motley Fool • Aug 18, 2026

A Doximity Director Moved 7,500 Shares the Day the Stock Popped 33%. Here's What to Know

Cabral sold 7,500 shares for an estimated $293,000 on August 7. The disposition involved the exercise of stock options followed by an immediate open-market sale.

The Motley Fool • Aug 18, 2026

Atlassian and Doximity Just Surged 30% After Earnings: 3 Software Stocks with the Same Setup

Recent commentary in the DevSecOps sector has been positive, which could help fuel GitLab's revenue. UiPath is a highly shorted stock that could defy expectations.

The Motley Fool • Aug 11, 2026

Why Doximity Stock Skyrocketed on Friday

Doximity's AI assistant is earning favorable reviews from independent researchers. Customer usage of Doximity's AI services is soaring.

The Motley Fool • Aug 8, 2026

Doximity Q1 Earnings Call Highlights

Doximity NYSE: DOCS reported fiscal 2027 first-quarter revenue of $157 million, up 7% from a year earlier, as the company cited improving demand from pharmaceutical and hospital customers and increased engagement with its clinical artificial intelligence tools.

MarketBeat • Aug 8, 2026